Malignant Mesothelioma Therapeutic Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Malignant Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Malignant Mesothelioma and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Inquire more about this report http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=395203 . (This is a premium report price at US$2000 for a single user PDF license)

The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.

Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Complete Report is available at http://www.rnrmarketresearch.com/malignant-mesothelioma-pipeline-review-h1-2015-market-report.html .

Scope of the Report:

• Coverage of the Malignant Mesothelioma pipeline on the basis of target, MoA, route of administration and molecule type

• A detailed assessment of monotherapy and combination therapy pipeline...